Compare TBPH & YEXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBPH | YEXT |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 993.7M | 981.0M |
| IPO Year | N/A | 2017 |
| Metric | TBPH | YEXT |
|---|---|---|
| Price | $20.04 | $7.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $27.80 | $9.44 |
| AVG Volume (30 Days) | 439.2K | ★ 862.7K |
| Earning Date | 02-25-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.58 | 0.00 |
| Revenue | $80,327,000.00 | ★ $447,666,000.00 |
| Revenue This Year | $70.78 | $8.66 |
| Revenue Next Year | N/A | $4.77 |
| P/E Ratio | ★ $34.48 | $35.37 |
| Revenue Growth | ★ 27.12 | 9.46 |
| 52 Week Low | $7.90 | $5.51 |
| 52 Week High | $20.79 | $9.20 |
| Indicator | TBPH | YEXT |
|---|---|---|
| Relative Strength Index (RSI) | 62.84 | 30.84 |
| Support Level | $18.41 | $7.77 |
| Resistance Level | $20.79 | $7.79 |
| Average True Range (ATR) | 0.71 | 0.17 |
| MACD | 0.12 | -0.05 |
| Stochastic Oscillator | 76.62 | 22.22 |
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.